Kalnik Matthew W. 4
4 · NABI BIOPHARMACEUTICALS · Filed Apr 5, 2011
Insider Transaction Report
Form 4
Kalnik Matthew W.
SVP Strategic Plan. & Bus. Ops
Transactions
- Award
Common Stock
2011-04-01+30,000→ 71,050 total - Sale
Common Stock
2011-04-01$5.80/sh−6,300$36,530→ 41,050 total - Award
Stock Option (right to buy)
2011-04-01+75,000→ 75,000 totalExercise: $5.81Exp: 2018-04-01→ Common Stock (75,000 underlying)
Footnotes (3)
- [F1]The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Restricted Stock which vests in four equal annual installments beginning on April 1, 2012.
- [F3]This Option will become exercisable in four equal annual installments beginning on April 1, 2012.